Polypharmacy in Patients With Ovarian Cancer

Oncologist - United States
doi 10.1634/theoncologist.2018-0807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

Use of Hepatoprotectors in Patients With Ovarian Cancer

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2015English

Plasma Immune Analytes in Patients With Epithelial Ovarian Cancer

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2015English

Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

New England Journal of Medicine
Medicine
2019English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Polypharmacy in Older Patients With Chronic Diseases: A Cross-Sectional Analysis of Factors Associated With Excessive Polypharmacy

BMC Family Practice
Family Practice
2018English

Immunotherapy With Checkpoint Inhibitors in Patients With Ovarian Cancer: Still Promising?

Cancer
Cancer ResearchOncology
2019English

Palliative Care in Patients With Ovarian Cancer and Bowel Obstruction

Supportive Care in Cancer
Oncology
2015English

IMGN853 Is Active in Patients With FRα-Positive Ovarian Cancer

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy